What is Chrysalis ABA?
Chrysalis ABA operates at the intersection of clinical excellence and developmental support, specializing in Applied Behavior Analysis (ABA) therapy. The firm provides a comprehensive suite of services tailored to individuals diagnosed with Autism Spectrum Disorder and various developmental disabilities. By utilizing structured one-on-one sessions, the company facilitates essential skill acquisition, ranging from communication development to social integration. Their operational model is distinguished by a dual focus on direct patient care and robust caregiver training, ensuring that therapeutic progress is sustained beyond the clinical environment. Through integrated care coordination and personalized tutoring, Chrysalis ABA maintains a strong market position as a provider of evidence-based behavioral health solutions.
How much funding has Chrysalis ABA raised?
Chrysalis ABA has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in Chrysalis ABA
PPP
Public-Private Partnership
What's next for Chrysalis ABA?
With the recent influx of capital, Chrysalis ABA is poised to accelerate its strategic expansion, likely focusing on increasing its geographic footprint and enhancing its digital care coordination platforms. As the organization transitions through this late-stage growth phase, the primary objective will be to optimize service delivery models while maintaining the rigorous standards of care that define its brand. Future initiatives will likely involve scaling the workforce of certified behavioral technicians and investing in proprietary data analytics to track long-term patient outcomes. By leveraging this financial backing, the company is set to solidify its leadership in the developmental disability services market, addressing the growing demand for accessible, high-quality behavioral health interventions.
See full Chrysalis ABA company page
